Sunday, May 8, 2022 8:00 AM – 10:00 AM ET Oregon Ballroom 201
Infection and Disease
- Marta Catalfamo, Georgetown Univ. Sch. of Med.
- Bethany Mundy-Bosse, The Ohio State Univ. Col. of Med.
- Tanya Novak, Boston Children’s Hosp. and Harvard Med. Sch., Genes associated with multiple organ dysfunction syndrome during severe pediatric influenza
- Julie G. Burel, La Jolla Inst. for Immunology, Profiling the myeloid compartment of PBMC in active tuberculosis reveals substantial changes in CD14+ cells and upregulation of CD16 in pro-inflammatory dendritic cells
- Jeffrey Alan Tomalka, Emory Univ. Sch. of Med., Inflammasomes and IL-1β: an innate immune axis in CD4+ T cells driving HIV infection and disease progression
- Hadas Tamar Pahima, Hebrew Univ. of Jerusalem, COVID-19 patients are characterized by increased levels of immune cell membrane-bound and soluble CD48
- Sarah C. Glover, Univ. of Mississippi Med. Ctr., Circulating extracellular vesicles from patients with severe COVID-19 upregulate Cathepsin B and activate STAT3 in normal human mesangial cells
- Josh S. Mytych, Oklahoma Med. Res. Fndn., Bacillus anthracis peptidoglycan alters human M2-like macrophage phenotype and efferocytic function in the presence of human serum
- Ismaila L. Manneh, London Sch. of Hygiene and Tropical Med., Targeted transcriptomic signature for monitoring anti-tuberculosis treatment response
- Yashoda Madaiah Hosakote, Univ. of Texas Med. Br. at Galveston, SARS-CoV-2 induced oxidative stress promotes HMGB1 secretion to induce inflammation